Stroke |
|
|
Symptoms |
|
|
F (face)-
weakness or drooping, crooked smile, sudden loss of vision in one or both
eyes |
|
|
A (arms) -
weak or drooping arm |
|
|
S (speech) -
slurred or inability to understand or be understood; inability to speak |
|
|
T (time) - 4-5
minutes without oxygen causes brain cell death (IRREVERSIBLE) |
|
|
NIH Stroke Scale |
|
|
|
Risk Factors |
|
|
Controllable/Treatable
Risk Factors |
|
|
1. High Blood
Pressure (140/90 or higher) - most important risk factor for stroke |
|
|
2. Tobacco use
- major risk factor |
|
|
3. Diabetes
mellitus |
|
|
4. Carotid or
artery disease or peripheral artery disease |
|
|
5. Atrial
fibrillation |
|
|
6. Other heart diseases -
coronary heart disease, dilated cardiomyopathy, heart valve disease,
congenital heart defects, etc. |
|
|
|
|
7. Transient ischemic attacks
(TIA) - mini-strokes, which are warning signs of potential major stroke -
patients with TIA's should be on antiplatelet regimen (i.e. aspirin, plavix,
or aspirin + dipyridamole) |
|
|
|
|
|
|
8. Elevated red blood cell count
- can be treated with blood thinners or removing excess red blood cells |
|
|
|
|
9. Sickle cell
disease |
|
|
10. Elevated
Cholesterol |
|
|
11. Physical
Inactivity or Obesity |
|
|
12. Excessive
alcohol intake |
|
|
13. Certain
illicit drugs (IV drug abuse, cocaine) |
|
|
|
|
|
Uncontrollable
Risk Factors |
|
|
1. Increasing
age |
|
|
2. Sex
(gender) - more common in men |
|
|
3. Family
history |
|
|
4. Prior
stroke or heart attack - increases risk |
|
|
|
|
|
Acute
Management of Ischemic Stroke |
|
|
Before any treatment, hemorrhagic stroke must be ruled out by CT scan |
|
|
Any thrombolytic treatment must
be initiated within three (3) hours of onset of stroke symptoms (i.e. tPA) |
|
|
|
|
Medications |
|
|
1. tPA - total dose
(recommended): 0.9mg/kg (maximum dose should not exceed 90mg) infused over 60
minutes. Load with 0.09mg/kg (10% of
the 0.9mg/kg dose) as an IV bolus over 1 minute, followed by 0.81mg/kg (90%
of the 0.9mg/kg dose) as a continuous infusion over 60 minutes. Heparin should not be started for 24 hours or more after starting alteplase (tPA)
for stroke |
|
|
|
|
|
|
|
|
|
|
2. Aspirin 300mg should be given
as soon as possible after the onset of stroke symptoms (unless being treated
with thrombolytic agents - then should be held for 24 hours after treatment
with thrombolytic). Aspirin (50-300mg)
should be continued indefinitely until an alternative antiplatelet therapy is
initiated |
|
|
|
|
|
|
|
|
Thus far, none of the medications
aimed at salvaging ischemic brain (i.e. neuroprotectors and drugs to reduce
cerebral edema) have been approved for routine use |
|
|
|
|
|
|
|
Acute
Management of Subarachnoid Hemorrhagic Stroke |
|
|
CT scan should be undertaken
immediately if the patient has impaired level of consciousness, otherwise CT
scan should be undertaken within 12 hours |
|
|
|
|
Once diagnosis
confimred: |
|
|
1. Nimodipine
60mg every 4 hours should be initiated (unless contraindicated) |
|
|
2.
Anti-fibrinolytic agents and steroids should not be given |
|
|
3. General supportive measures to
ensure adequate hydration and oxygenation should be instituted (including
pain management) |
|
|
|
|
|
|
|
Secondary
Prevention |
|
|
should be
initiated within 7 days of acute stroke or TIA |
|
|
1. Lifestyle modifications -
smoking cessation, regular exercise, modifying diet, reduced salt intake, and
avoiding excess alcohol |
|
|
|
|
2. Blood pressure control - if
blood pressure elevated for over two weeks, should be treated to keep
<140/85 in all non-diabetic patients and <130/80 in diabetic patients
(first line therapy should be ACE-I or ARB +/- diuretic (usually thiazide diuretic)) |
|
|
|
|
|
|
3. Anti-thrombotic therapy - all post-stroke patients should be on
antiplatelet therapy (i.e. aspirin 50-300mg daily, plavix, or combination of
aspirin plus dipyridamole modified release (aggrenox)) |
|
|
|
|
|
|
4. Anti-lipid therapy - all post-stroke patient's should be
initiated on Zocor 40mg daily, unless contraindicated |
|
|
|
|
5.
Anticoagulation therapy should not
be routinely initiated, unless atrial fibrillation present |
|
|
|
|
|
|
|
|
|
Return
to Main Index |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|